A
Abbott India Ltd
NSE:ABBOTINDIA
Abbott India Ltd
NSE:ABBOTINDIA
Price:
26 515
INR
0.21%
Market Cap:
₹563.4B
Relative Value
The Relative Value of one ABBOTINDIA stock under the Base Case scenario is 24 994.58 INR. Compared to the current market price of 26 515 INR, Abbott India Ltd is Overvalued by 6%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ABBOTINDIA
Relative Value
Base Case
24 994.58
INR
Overvaluation 6%
A
Multiples Across Competitors
ABBOTINDIA Competitors Multiples
Abbott India Ltd Competitors
Abbott India Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
A
|
Abbott India Ltd
NSE:ABBOTINDIA
|
562.7B INR | 8.4 | 37.3 | 29.9 | 31.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
986.4B USD | 15.1 | 47.7 | 32.2 | 34.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.1B USD | 6.2 | 21.9 | 15.2 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
286.3B CHF | 4.7 | 30.5 | 12.9 | 15 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
235.3B GBP | 5.5 | 31.3 | 17.3 | 24.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
239B CHF | 5.5 | 22 | 13.6 | 17.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
301.2B USD | 4.6 | 16.5 | 10.3 | 12.1 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.5 | 13.5 | 9.9 | 11.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.3B USD | 2.5 | 20.2 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.4B USD | 2.6 | 17.5 | 6.8 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
